Advertisement
Screener

ABEONA THERAPEUTICS INC. (ABEO) Increase (Decrease) in Receivables

2.8 / 5 stars · 68/120 Roast Me

ABEONA THERAPEUTICS INC. Increase (Decrease) in Receivables

ABEONA THERAPEUTICS INC. (ABEO) reported Increase (Decrease) in Receivables of -$3.00 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInReceivables · last filed 2022-05-13

  • ABEONA THERAPEUTICS INC. increase (decrease) in receivables for the quarter ending 2022-03-31 was -$3.00M.
  • ABEONA THERAPEUTICS INC. increase (decrease) in receivables for the quarter ending 2019-12-31 was -$15.00K.
  • ABEONA THERAPEUTICS INC. increase (decrease) in receivables for the quarter ending 2019-09-30 was -$25.00K, a 108.20% decline year-over-year.
  • ABEONA THERAPEUTICS INC. increase (decrease) in receivables for the quarter ending 2019-06-30 was $2.00K.
  • ABEONA THERAPEUTICS INC. increase (decrease) in receivables for fiscal 2021 was $3.00M.
  • ABEONA THERAPEUTICS INC. increase (decrease) in receivables for fiscal 2019 was -$81.00K.
  • ABEONA THERAPEUTICS INC. increase (decrease) in receivables for fiscal 2018 was -$26.00K.
  • ABEONA THERAPEUTICS INC. increase (decrease) in receivables for fiscal 2017 was -$17.00K, a 288.89% decline from fiscal 2016.
Period endIncrease (Decrease) in Receivables 3 monthIncrease (Decrease) in Receivables 6 monthIncrease (Decrease) in Receivables 6 month as first filedIncrease (Decrease) in Receivables 9 monthIncrease (Decrease) in Receivables 9 month as first filedIncrease (Decrease) in Receivables 12 month
2022-03-31-$3.00M
10-Q · filed 2022-05-13
2021-12-31$3.00M
10-K · filed 2022-03-31
2020-09-30$7.00M
10-Q · filed 2021-11-15
2019-12-31-$15.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24
-$40.00K
derived: sum of 2 quarters · filed 2021-03-24
-$38.00K
derived: sum of 3 quarters · filed 2021-03-24
-$81.00K
10-K · filed 2021-03-24
2019-09-30-$25.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
-$23.00K
derived: sum of 2 quarters · filed 2020-11-09
-$66.00K
10-Q · filed 2020-11-09
-$337.00K
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30$2.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$41.00K
10-Q · filed 2020-08-10
-$312.00K
derived: sum of 3 quarters · filed 2020-08-10
-$7.00K
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31-$43.00K
10-Q · filed 2020-05-06
-$314.00K
derived: sum of 2 quarters · filed 2020-05-06
-$9.00K
derived: sum of 3 quarters · filed 2020-05-06
-$26.00K
derived: sum of 4 quarters · filed 2020-05-06
2018-12-31-$271.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$34.00K
derived: sum of 2 quarters · filed 2020-03-16
$17.00K
derived: sum of 3 quarters · filed 2020-03-16
-$26.00K
10-K · filed 2020-03-16
2018-09-30$305.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$288.00K
derived: sum of 2 quarters · filed 2019-11-12
$245.00K
10-Q · filed 2019-11-12
$241.00K
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30-$17.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$60.00K
10-Q · filed 2019-08-09
-$64.00K
derived: sum of 3 quarters · filed 2020-03-16
-$50.00K
derived: sum of 4 quarters · filed 2020-03-16
2018-03-31-$43.00K
10-Q · filed 2019-05-10
-$47.00K
derived: sum of 2 quarters · filed 2020-03-16
-$33.00K
derived: sum of 3 quarters · filed 2020-03-16
-$84.00K
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31-$4.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$10.00K
derived: sum of 2 quarters · filed 2020-03-16
-$41.00K
derived: sum of 3 quarters · filed 2020-03-16
-$17.00K
10-K · filed 2020-03-16
2017-09-30$14.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
-$37.00K
derived: sum of 2 quarters · filed 2018-11-09
-$13.00K
10-Q · filed 2018-11-09
-$495.00K
derived: sum of 4 quarters · filed 2019-03-18
2017-06-30-$51.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$27.00K
10-Q · filed 2018-08-09
-$509.00K
derived: sum of 3 quarters · filed 2019-03-18
-$15.00K
derived: sum of 4 quarters · filed 2019-03-18
2017-03-31$24.00K
10-Q · filed 2018-05-10
-$458.00K
derived: sum of 2 quarters · filed 2019-03-18
$36.00K
derived: sum of 3 quarters · filed 2019-03-18
-$96.00K
derived: sum of 4 quarters · filed 2019-03-18
2016-12-31-$482.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$12.00K
derived: sum of 2 quarters · filed 2019-03-18
-$120.00K
derived: sum of 3 quarters · filed 2019-03-18
$9.00K
10-K · filed 2019-03-18
2016-09-30$494.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$362.00K
derived: sum of 2 quarters · filed 2017-11-14
$491.00K
10-Q · filed 2017-11-14
$335.00K
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30-$132.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
-$3.00K
10-Q · filed 2017-08-14
-$159.00K
derived: sum of 3 quarters · filed 2017-08-14
-$218.00K
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$129.00K
10-Q · filed 2017-05-15
-$27.00K
derived: sum of 2 quarters · filed 2017-05-15
-$86.00K
derived: sum of 3 quarters · filed 2017-05-15
$99.00K
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31-$156.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30
-$215.00K
derived: sum of 2 quarters · filed 2017-03-30
-$30.00K
derived: sum of 3 quarters · filed 2017-03-30
$79.00K
10-K · filed 2017-03-30
2015-09-30-$59.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$126.00K
derived: sum of 2 quarters · filed 2016-11-14
$235.00K
10-Q · filed 2016-11-14
$267.00K
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30$185.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
$294.00K
10-Q · filed 2016-08-15
$326.00K
derived: sum of 3 quarters · filed 2016-08-15
$271.00K
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31$109.00K
10-Q · filed 2016-05-16
$141.00K
derived: sum of 2 quarters · filed 2016-05-16
$86.00K
derived: sum of 3 quarters · filed 2016-05-16
$85.00K
derived: sum of 4 quarters · filed 2016-05-16
2014-12-31$32.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
-$23.00K
derived: sum of 2 quarters · filed 2016-03-30
-$24.00K
derived: sum of 3 quarters · filed 2016-03-30
-$39.00K
10-K · filed 2016-03-30
2014-09-30-$55.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16
-$56.00K
derived: sum of 2 quarters · filed 2015-11-16
-$71.00K
10-Q · filed 2015-11-16
-$53.00K
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30-$1.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14
-$16.00K
10-Q · filed 2015-08-14
$2.00K
derived: sum of 3 quarters · filed 2015-08-14
-$201.00K
derived: sum of 4 quarters · filed 2015-08-14
2014-03-31-$15.00K
10-Q · filed 2015-05-14
$3.00K
derived: sum of 2 quarters · filed 2015-05-14
-$200.00K
derived: sum of 3 quarters · filed 2015-05-14
-$1.17M
derived: sum of 4 quarters · filed 2015-05-14
2013-12-31$18.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31
-$185.00K
derived: sum of 2 quarters · filed 2015-03-31
-$1.16M
derived: sum of 3 quarters · filed 2015-03-31
-$766.00K
10-K · filed 2015-03-31
2013-09-30-$203.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14
-$1.18M
derived: sum of 2 quarters · filed 2014-11-14
-$784.00K
10-Q · filed 2014-11-14
-$425.00K
derived: sum of 4 quarters · filed 2014-11-14
2013-06-30-$972.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
-$581.00K
10-Q · filed 2014-08-14
-$222.00K
derived: sum of 3 quarters · filed 2014-08-14
-$529.00K
derived: sum of 4 quarters · filed 2014-08-14
2013-03-31$391.00K
10-Q · filed 2014-05-12
$750.00K
derived: sum of 2 quarters · filed 2014-05-12
$443.00K
derived: sum of 3 quarters · filed 2014-05-12
$297.00K
derived: sum of 4 quarters · filed 2014-05-12
2012-12-31$359.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26
$52.00K
derived: sum of 2 quarters · filed 2014-03-26
-$94.00K
derived: sum of 3 quarters · filed 2014-03-26
$507.00K
10-K · filed 2014-03-26
2012-09-30-$307.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14
-$453.00K
derived: sum of 2 quarters · filed 2013-11-14
$148.00K
10-Q · filed 2013-11-14
$362.00K
derived: sum of 4 quarters · filed 2013-11-14
2012-06-30-$146.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
$455.00K
10-Q · filed 2013-08-14
$669.00K
derived: sum of 3 quarters · filed 2013-08-14
$737.00K
derived: sum of 4 quarters · filed 2013-08-14
2012-03-31$601.00K
10-Q · filed 2013-05-15
$815.00K
derived: sum of 2 quarters · filed 2013-05-15
$883.00K
derived: sum of 3 quarters · filed 2013-05-15
$888.00K
derived: sum of 4 quarters · filed 2013-05-15
2011-12-31$214.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20
$282.00K
derived: sum of 2 quarters · filed 2013-03-20
$287.00K
derived: sum of 3 quarters · filed 2013-03-20
-$685.00K
10-K · filed 2013-03-20
2011-09-30$68.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14
$73.00K
derived: sum of 2 quarters · filed 2012-11-14
-$899.00K
10-Q · filed 2012-11-14
$899.00K
10-Q · filed 2011-11-14
$87.00K
derived: sum of 4 quarters · filed 2012-11-14
2011-06-30$5.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14
-$967.00K
10-Q · filed 2012-08-14
$967.00K
10-Q · filed 2011-08-15
$19.00K
derived: sum of 3 quarters · filed 2012-08-14
$17.00K
derived: sum of 4 quarters · filed 2012-08-14
2011-03-31-$972.00K
10-Q · filed 2012-05-15
$14.00K
derived: sum of 2 quarters · filed 2012-05-15
$12.00K
derived: sum of 3 quarters · filed 2012-05-15
2010-12-31$986.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-23
$984.00K
derived: sum of 2 quarters · filed 2012-03-23
$982.00K
10-K · filed 2012-03-23
2010-09-30-$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
-$4.00K
10-Q · filed 2011-11-14
2010-06-30-$2.00K
10-Q · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Evommune, Inc. (EVMN)United States$0.320B-5.10
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40